Your browser is no longer supported. Please, upgrade your browser.
AMPH Amphastar Pharmaceuticals, Inc. daily Stock Chart
AMPH [NASD]
Amphastar Pharmaceuticals, Inc.
Index- P/E19.48 EPS (ttm)1.04 Insider Own7.00% Shs Outstand46.41M Perf Week-7.21%
Market Cap961.88M Forward P/E16.19 EPS next Y1.26 Insider Trans-9.25% Shs Float35.08M Perf Month1.09%
Income52.00M PEG0.78 EPS next Q0.14 Inst Own53.30% Short Float8.05% Perf Quarter23.50%
Sales327.30M P/S2.94 EPS this Y892.90% Inst Trans0.03% Short Ratio8.17 Perf Half Y8.71%
Book/sh8.13 P/B2.50 EPS next Y103.90% ROA8.90% Target Price22.20 Perf Year1.65%
Cash/sh1.42 P/C14.36 EPS next 5Y25.00% ROE13.50% 52W Range12.32 - 22.85 Perf YTD5.44%
Dividend- P/FCF80.16 EPS past 5Y42.40% ROI-3.20% 52W High-10.98% Beta1.18
Dividend %- Quick Ratio1.70 Sales past 5Y8.90% Gross Margin42.10% 52W Low65.03% ATR0.65
Employees2027 Current Ratio3.00 Sales Q/Q6.10% Oper. Margin3.20% RSI (14)44.72 Volatility2.58% 2.96%
OptionableYes Debt/Eq0.13 EPS Q/Q375.30% Profit Margin15.90% Rel Volume0.29 Prev Close20.34
ShortableYes LT Debt/Eq0.10 EarningsMay 07 AMC Payout0.00% Avg Volume345.38K Price20.34
Recom2.60 SMA20-3.96% SMA503.63% SMA20010.21% Volume27,864 Change0.00%
May-01-20Initiated Northland Capital Outperform $23
Mar-13-19Downgrade Piper Jaffray Overweight → Neutral $24 → $23
Mar-13-19Downgrade Needham Buy → Hold
Aug-10-18Reiterated Needham Buy $24 → $22
Mar-13-18Reiterated Needham Buy $23 → $24
Dec-01-17Reiterated Needham Buy $20 → $23
Nov-09-17Downgrade Raymond James Outperform → Mkt Perform
Sep-27-17Reiterated Needham Buy $18 → $20
Mar-14-17Downgrade Raymond James Strong Buy → Outperform
Aug-09-16Reiterated Needham Buy $20 → $22
May-10-16Reiterated Needham Buy $21 → $20
Feb-19-16Initiated Wells Fargo Outperform
Jun-19-15Reiterated Needham Buy $17 → $21
Jun-03-15Initiated Raymond James Strong Buy
Jul-21-14Initiated Needham Buy $17
Jul-03-20 11:59AM  
Jun-19-20 06:05AM  
Jun-12-20 04:17PM  
06:30AM  
Jun-11-20 02:45PM  
Jun-09-20 09:52AM  
06:00AM  
Jun-02-20 04:05PM  
May-11-20 01:24AM  
May-09-20 08:21AM  
May-08-20 04:31PM  
May-07-20 04:05PM  
May-06-20 12:10PM  
May-04-20 06:01AM  
Apr-27-20 06:00AM  
Apr-13-20 05:16PM  
Apr-09-20 06:01AM  
Mar-31-20 10:56AM  
Mar-29-20 08:36AM  
Mar-25-20 09:33AM  
Mar-24-20 09:47AM  
Mar-20-20 10:44AM  
Mar-12-20 06:05PM  
04:05PM  
03:00PM  
Mar-05-20 04:05PM  
Mar-03-20 12:30PM  
Feb-27-20 06:00AM  
Feb-13-20 05:48AM  
Jan-29-20 08:30AM  
Jan-28-20 04:05PM  
Jan-08-20 05:15AM  
Dec-17-19 07:19PM  
Dec-10-19 10:25PM  
Dec-02-19 05:16AM  
Nov-27-19 06:00AM  
Nov-15-19 06:00AM  
Nov-07-19 04:05PM  
Nov-01-19 06:00AM  
Oct-28-19 02:14PM  
Oct-21-19 06:17AM  
Sep-21-19 07:58AM  
Sep-12-19 09:15PM  
Sep-01-19 09:38PM  
Aug-29-19 06:01AM  
Aug-22-19 08:44AM  
Aug-07-19 11:24PM  
08:55PM  
04:05PM  
Aug-05-19 06:00AM  
Jul-23-19 01:19PM  
Jun-29-19 06:18PM  
Jun-24-19 06:00AM  
Jun-19-19 06:00AM  
Jun-14-19 02:07PM  
06:00AM  
May-31-19 06:00AM  
May-28-19 02:47PM  
May-21-19 01:33AM  
May-10-19 06:00AM  
12:24AM  
May-09-19 07:05PM  
05:58PM  
04:05PM  
May-07-19 10:56AM  
May-06-19 06:00AM  
May-01-19 10:33AM  
Apr-26-19 09:30AM  
Apr-25-19 03:13PM  
Apr-15-19 09:30AM  
Apr-10-19 09:30AM  
Mar-26-19 05:32PM  
Mar-25-19 09:30AM  
Mar-21-19 12:06AM  
Mar-19-19 07:40AM  
06:00AM  
Mar-15-19 07:48AM  
Mar-13-19 04:17PM  
10:24AM  
02:36AM  
Mar-12-19 07:10PM  
06:16PM  
04:05PM  
03:00PM  
07:31AM  
Mar-08-19 09:30AM  
Mar-07-19 04:01PM  
Feb-26-19 08:15AM  
Feb-13-19 09:30AM  
Jan-29-19 01:38PM  
Jan-28-19 09:30AM  
Jan-11-19 09:30AM  
Jan-03-19 06:00AM  
Dec-25-18 09:30AM  
Dec-23-18 09:20PM  
Dec-21-18 11:04AM  
Dec-03-18 08:52AM  
Nov-27-18 08:45AM  
Nov-22-18 09:30AM  
Nov-21-18 10:42AM  
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; naloxone for opioid overdose; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; and Cortrosyn, a lyophilized powder use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; lidocaine jelly, a local anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection for newborn babies; atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate for emergency use in hospital settings; morphine injection; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as recombinant human insulin API (active pharmaceutical ingredients) and porcine insulin API. Further, the company has a pipeline of 20 product candidates in various stages of development for various indications. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PETERS WILLIAM JCFO, SVP & TreasurerJul 06Option Exercise11.3310,000113,300114,820Jul 08 04:05 PM
PETERS WILLIAM JCFO, SVP & TreasurerJul 06Sale22.0013,656300,405101,164Jul 08 04:05 PM
Petersen Floyd F.DirectorJul 01Sale22.2750011,13676,493Jul 02 07:36 PM
Liawatidewi YakobEVP Corp Admin CenterJun 09Option Exercise10.9316,000174,88069,529Jun 10 07:39 PM
Liawatidewi YakobEVP Corp Admin CenterJun 09Sale20.4123,405477,60246,124Jun 10 07:39 PM
Zhou RongEVP, Production CenterJun 04Option Exercise11.418,918101,75489,042Jun 05 04:15 PM
Zhou RongEVP, Production CenterJun 04Sale19.199,806188,17779,236Jun 05 04:15 PM
Zhou RongEVP, Production CenterJun 03Option Exercise11.4111,082126,44693,287Jun 05 04:15 PM
Zhou RongEVP, Production CenterJun 03Sale18.8213,163247,67880,124Jun 05 04:15 PM
Petersen Floyd F.DirectorJun 01Sale18.975009,48371,142Jun 02 05:46 PM
Koo RichardDirectorMay 27Option Exercise15.1147,782721,986295,201May 28 04:05 PM
Koo RichardDirectorMay 27Sale18.1847,782868,892247,419May 28 04:05 PM
Lee HowardDirectorMay 26Option Exercise15.1110,000151,100138,081May 27 05:02 PM
Lee HowardDirectorMay 26Sale18.6010,000185,989128,081May 27 05:02 PM
Lee HowardDirectorMay 22Option Exercise15.1110,000151,100138,081May 27 05:02 PM
Lee HowardDirectorMay 22Sale18.3610,000183,639128,081May 27 05:02 PM
Lee HowardDirectorMay 21Option Exercise15.1110,000151,100138,081May 22 04:05 PM
Lee HowardDirectorMay 21Sale18.4710,000184,687128,081May 22 04:05 PM
Lee HowardDirectorMay 20Option Exercise15.1117,782268,686145,863May 22 04:05 PM
Lee HowardDirectorMay 20Sale18.4317,782327,779128,081May 22 04:05 PM
ZASLOFF MICHAEL ADirectorMay 15Option Exercise15.1122,950346,77558,286May 18 04:36 PM
Petersen Floyd F.DirectorMay 15Option Exercise15.1142,682644,925114,324May 18 04:31 PM
Petersen Floyd F.DirectorMay 15Sale18.2542,682778,96871,642May 18 04:31 PM
ZASLOFF MICHAEL ADirectorMay 15Sale18.0322,950413,68135,336May 18 04:36 PM
Petersen Floyd F.DirectorMay 14Option Exercise15.115,00075,55076,642May 18 04:31 PM
ZASLOFF MICHAEL ADirectorMay 14Option Exercise15.1114,832224,11250,168May 18 04:36 PM
ZASLOFF MICHAEL ADirectorMay 14Sale18.0014,832266,97635,336May 18 04:36 PM
Petersen Floyd F.DirectorMay 14Sale17.785,00088,87671,642May 18 04:31 PM
Petersen Floyd F.DirectorMay 12Option Exercise15.111001,51171,742May 14 04:15 PM
PRINS RICHARD KDirectorMay 12Option Exercise15.1130,282457,56169,591May 14 04:17 PM
ZASLOFF MICHAEL ADirectorMay 12Option Exercise15.1110,000151,10045,336May 14 04:18 PM
ZASLOFF MICHAEL ADirectorMay 12Sale19.0010,000190,00035,336May 14 04:18 PM
PRINS RICHARD KDirectorMay 12Sale19.0030,282575,41939,309May 14 04:17 PM
Petersen Floyd F.DirectorMay 12Sale19.201001,92071,642May 14 04:15 PM
Petersen Floyd F.DirectorMay 01Sale16.665008,32971,642May 05 05:05 PM
Petersen Floyd F.DirectorApr 01Sale14.365007,18172,142Apr 02 05:46 PM
PETERS WILLIAM JCFO, SVP & TreasurerMar 13Sale13.944,70165,53974,274Mar 17 08:07 PM
Petersen Floyd F.DirectorMar 02Sale15.565007,78272,642Mar 03 04:15 PM
Shandell Jason B.President and General CounselFeb 07Option Exercise14.406,85398,683145,751Feb 07 08:08 PM
Shandell Jason B.President and General CounselFeb 07Sale19.886,853136,260138,898Feb 07 08:08 PM
Shandell Jason B.President and General CounselFeb 06Option Exercise14.4021,933315,835160,831Feb 07 08:08 PM
Shandell Jason B.President and General CounselFeb 06Sale19.8321,933434,951138,898Feb 07 08:08 PM
Shandell Jason B.President and General CounselFeb 05Option Exercise14.4015,615224,856154,513Feb 07 08:08 PM
Shandell Jason B.President and General CounselFeb 05Sale19.5715,615305,554138,898Feb 07 08:08 PM
Petersen Floyd F.DirectorFeb 03Sale19.125009,55873,142Feb 04 04:07 PM
PETERS WILLIAM JCFO, SVP & TreasurerJan 21Sale20.073,99080,07178,975Jan 23 04:05 PM
Shandell Jason B.President and General CounselJan 08Option Exercise10.9325,000273,250163,898Jan 10 04:05 PM
Shandell Jason B.President and General CounselJan 08Sale18.4425,000460,978138,898Jan 10 04:05 PM
Petersen Floyd F.DirectorJan 02Sale19.141,00019,14273,642Jan 03 05:05 PM
Shandell Jason B.President and General CounselDec 18Sale19.138,205156,958138,898Dec 20 04:06 PM
Petersen Floyd F.DirectorDec 02Sale19.255009,62374,642Dec 04 04:06 PM
Petersen Floyd F.DirectorNov 01Sale19.485009,73875,142Nov 05 04:06 PM
Petersen Floyd F.DirectorOct 01Sale19.925009,95975,642Oct 03 06:21 PM
Shandell Jason B.President and General CounselSep 18Sale21.327,340156,509147,103Sep 20 04:05 PM
PETERS WILLIAM JCFO, SVP & TreasurerSep 16Option Exercise11.339,800111,03492,253Sep 18 04:32 PM
PETERS WILLIAM JCFO, SVP & TreasurerSep 16Sale21.769,800213,25682,453Sep 18 04:32 PM
Petersen Floyd F.DirectorSep 16Sale21.7550010,87776,142Sep 17 08:13 PM
Liawatidewi YakobSVP Corp Admin CenterSep 13Sale21.453,00064,34033,670Sep 17 07:11 PM
Zhang Jack Y.CEO & Chief Scientific OfficerSep 11Sale20.82300,0006,246,0007,027,679Sep 12 07:50 PM
Liawatidewi YakobSVP Corp Admin CenterSep 06Sale21.902,39552,4552,459Sep 09 08:16 PM
Liawatidewi YakobSVP Corp Admin CenterSep 05Sale21.241,51532,1844,854Sep 09 08:16 PM
PRINS RICHARD KDirectorAug 26Option Exercise15.113,61854,66842,927Aug 27 07:36 PM
PRINS RICHARD KDirectorAug 26Sale22.603,61881,76739,309Aug 27 07:36 PM
PRINS RICHARD KDirectorAug 23Option Exercise15.113,88258,65743,191Aug 27 07:36 PM
PRINS RICHARD KDirectorAug 23Sale22.583,88287,65439,309Aug 27 07:36 PM
PETERS WILLIAM JCFO, SVP & TreasurerAug 15Sale21.004,942103,78282,453Aug 16 05:07 PM
Liawatidewi YakobSVP Corp Admin CenterAug 13Option Exercise10.935,00054,65041,670Aug 14 05:18 PM
PRINS RICHARD KDirectorAug 13Option Exercise15.1110,000151,10049,309Aug 15 04:06 PM
PRINS RICHARD KDirectorAug 13Sale20.7810,000207,78139,309Aug 15 04:06 PM
Liawatidewi YakobSVP Corp Admin CenterAug 13Sale20.735,000103,65336,670Aug 14 05:18 PM
Liawatidewi YakobSVP Corp Admin CenterAug 12Option Exercise10.935,00054,65047,188Aug 14 05:18 PM
Liawatidewi YakobSVP Corp Admin CenterAug 12Sale20.4410,518214,96236,670Aug 14 05:18 PM